Logo
x

Search

Subscribe Now

JNJ

PharmaShots Weekly Snapshot (October 14-18, 2019)

PharmaShots Weekly Snapshot (October 14-18, 2019)

  • October 21, 2019
Janssen Presents P-I/II (MGT009) and P-I Study Results of Two Gene Therapy Programs for X-Linked Retinitis Pigmentosa and Dry AMD at AAO 2022

    Janssen Presents P-I/II (MGT009) and P-I Study Results of Two Gene Therapy Programs for X-Linked Retinitis Pigmentosa and Dry AMD...

    • October 3, 2022
    Insights+: Breakthrough Therapy Designation by the US FDA in 2020

      Insights+: Breakthrough Therapy Designation by the US FDA in 2020

      • March 11, 2021
      J&J Initiates Global P-III Clinical Study of its COVID-19 Vaccine

        J&J Initiates Global P-III Clinical Study of its COVID-19 Vaccine

        • September 24, 2020
        PharmaShots Weekly Snapshot (October 14-18, 2019)

          PharmaShots Weekly Snapshot (October 14-18, 2019)

          • October 21, 2019
          Image

          Incisive News in 3 Shots.

          Contact Us

          Our Information

          Follow Us

          Copyright © 2025 PharmaShots - All Rights Reserved.